WallStreetZenWallStreetZen

NASDAQ: VERA
Vera Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for VERA

Based on 7 analysts offering 12 month price targets for Vera Therapeutics Inc.
Min Forecast
$22.00-45.01%
Avg Forecast
$32.29-19.31%
Max Forecast
$56.00+39.97%

Should I buy or sell VERA stock?

Based on 7 analysts offering ratings for Vera Therapeutics Inc.
Strong Buy
Strong Buy
4 analysts 57.14%
Buy
2 analysts 28.57%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their VERA stock forecasts and price targets.

VERA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-05
lockedlocked$00.00+00.00%2024-03-21
lockedlocked$00.00+00.00%2024-01-26
lockedlocked$00.00+00.00%2024-01-25
lockedlocked$00.00+00.00%2023-12-27
JP Morgan
Bottom 20%
20
Strong BuyMaintains$22.00-45.01%2023-11-30
Jefferies
Top 40%
61
Strong BuyUpgrades$26.00-35.02%2023-11-10

1 of 1

Forecast return on equity

Is VERA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.72%

Forecast return on assets

Is VERA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

VERA revenue forecast

What is VERA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$20.5M
Avg 2 year Forecast
$115.9M
Avg 3 year Forecast
$328.7M

VERA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
VERA$40.01$32.29-19.31%Strong Buy
RCKT$23.68$54.33+129.45%Strong Buy
CLDX$39.63$66.00+66.54%Strong Buy
TGTX$13.82$27.50+98.99%Strong Buy
KROS$59.27$90.20+52.18%Strong Buy
View Top Biotech Stocks

Vera Therapeutics Stock Forecast FAQ

Is Vera Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: VERA) stock is to Strong Buy VERA stock.

Out of 7 analysts, 4 (57.14%) are recommending VERA as a Strong Buy, 2 (28.57%) are recommending VERA as a Buy, 1 (14.29%) are recommending VERA as a Hold, 0 (0%) are recommending VERA as a Sell, and 0 (0%) are recommending VERA as a Strong Sell.

If you're new to stock investing, here's how to buy Vera Therapeutics stock.

What is VERA's revenue growth forecast for 2026-2028?

(NASDAQ: VERA) Vera Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Vera Therapeutics's revenue in 2024 is $0.On average, 5 Wall Street analysts forecast VERA's revenue for 2026 to be $1,114,306,321, with the lowest VERA revenue forecast at $427,448,428, and the highest VERA revenue forecast at $1,783,303,950. On average, 4 Wall Street analysts forecast VERA's revenue for 2027 to be $6,310,717,901, with the lowest VERA revenue forecast at $4,425,860,917, and the highest VERA revenue forecast at $8,816,872,536.

In 2028, VERA is forecast to generate $17,900,396,657 in revenue, with the lowest revenue forecast at $11,702,285,552 and the highest revenue forecast at $25,496,618,059.

What is VERA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: VERA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is VERA's Price Target?

According to 7 Wall Street analysts that have issued a 1 year VERA price target, the average VERA price target is $32.29, with the highest VERA stock price forecast at $56.00 and the lowest VERA stock price forecast at $22.00.

On average, Wall Street analysts predict that Vera Therapeutics's share price could fall to $32.29 by Apr 5, 2025. The average Vera Therapeutics stock price prediction forecasts a potential downside of 19.31% from the current VERA share price of $40.01.

What is VERA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: VERA) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.